Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2013
08/07/2013CN103237800A Amide derivative and use thereof
08/07/2013CN103232473A Fluorenyl organic framework material, preparation and application method thereof
08/07/2013CN103232472A Bipolar bisthieno[3,2-b:2',3'-d] thiophene derivatives and applications thereof
08/07/2013CN103232471A 4,5-dihydrothieno[2,3-C]pyrrol-6-one synthesis method
08/07/2013CN101622234B Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
08/06/2013US8501961 HIV protease inhibitors and methods for using
08/06/2013US8501946 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine derivatives as P2X7 modulators
08/06/2013US8501750 Heterocyclic compound and use thereof
08/06/2013US8501741 Optically active compound of prulifloxacin for treating infection and preparation method thereof
08/06/2013CA2666603C Therapeutic pyrazolyl thienopyridines and uses thereof for treating tgf.beta. mediated conditions
08/06/2013CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
08/06/2013CA2586345C Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran
08/01/2013WO2013112699A2 Proteasome activity enhancing compounds
08/01/2013WO2013112622A1 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
08/01/2013WO2013111107A1 Aminopyridine derivatives as plasma kallikrein inhibitors
08/01/2013WO2013110433A1 Azaheterocyclic compounds
08/01/2013WO2013110135A1 Heterocyclic compounds and methods for their use
08/01/2013WO2010120994A3 Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
08/01/2013US20130196988 Dihydrothienopyrimidines
08/01/2013US20130196960 Cannabinoid Receptor Agonists
08/01/2013CA2861464A1 Proteasome activity modulating compounds
08/01/2013CA2861462A1 Proteasome activity enhancing compounds
08/01/2013CA2857969A1 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
07/2013
07/31/2013EP2619181A1 Novel microbiocides
07/31/2013CN103228661A Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/31/2013CN103228647A Materials for organic electroluminescent devices
07/30/2013CA2569530C Thienopyrazole derivative having pde 7 inhibitory activity
07/25/2013WO2013109045A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/25/2013WO2013108997A1 Compound for organic electronic device, and organic electronic device and electronic apparatus comprising same
07/25/2013WO2013108894A1 Fulvalene compound and method for producing same, fulvalene polymer, and solar cell material and organic transistor material
07/25/2013WO2013107743A1 Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists
07/25/2013WO2013107278A1 New-type anti-cancer compounds synthesized from reaction of ketone and indole derivatives
07/25/2013US20130190513 Novel organic compound and electrochromic element having the same
07/25/2013US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression
07/25/2013US20130190273 Methods for Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds
07/24/2013EP2618394A1 Organic electroluminescent element
07/24/2013EP2617726A1 Diabetes therapeutic agent
07/24/2013EP2617724A1 Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device
07/24/2013EP2617722A1 Hetero ring-fused imidazole derivative having ampk activating effect
07/24/2013EP2616472A2 Substituted 3,4-propylenedioxythiophene monomers and 3,4-propylenedioxythiophene-based crosslinkers and polymers thereof
07/24/2013EP2616471A1 Inhibitors of notum pectinacetylesterase and methods of their use
07/24/2013EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
07/24/2013EP2616442A1 Inhibitors of pi3k-delta and methods of their use and manufacture
07/24/2013CN103214490A Method for preparing novel organic field effect transistor material
07/24/2013CN103214470A Novel anticancer compound synthesized by reaction of ketone and indole derivative
07/24/2013CN102250487B Organic dye and application thereof in dye-sensitized solar cell
07/24/2013CN102206225B Polymer semiconducting material and organic thin film transistor
07/24/2013CN101212903B Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
07/23/2013US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
07/23/2013CA2716458C Methods for preparing benzodithiophenes
07/23/2013CA2585089C Fused pyrimidines and their use as inhibitors of pi3k
07/18/2013WO2013106535A1 Irak inhibitors and uses thereof
07/18/2013WO2013105747A1 Compound for organic electronic element, organic electronic element using same and electronic device thereof
07/18/2013WO2013105206A1 Material for organic electroluminescent element, and element using same
07/18/2013WO2013104575A1 Thienopyrimidine compounds
07/18/2013US20130184277 Adamantyl diamide derivatives and uses of same
07/18/2013US20130184265 Prodrugs of Secondary Amine Compounds
07/18/2013US20130184264 Compositions And Methods For Treating Neoplasia, Inflammatory Disease And Other Disorders
07/18/2013US20130184240 Hetero ring-fused imidazole derivative having ampk activating effect
07/18/2013US20130180589 Organic photovoltaic cell materials and components
07/17/2013EP2615657A1 Organic semiconductor material, organic semiconductor composition, organic thin film, field-effect transistor, and manufacturing method therefor
07/17/2013EP2615095A1 Benzodithiophene organic semiconductive material, preparation method and use thereof
07/17/2013EP2615088A1 Composition, synthesis and use of new substituted pyran and pterin compounds
07/17/2013EP2613783A1 Methods for the treatment or prophylaxis of thrombosis or embolism
07/17/2013CN103209981A Hetero ring-fused imidazole derivative having ampk activating effect
07/17/2013CN102276626B Isoxazole-containing compound
07/17/2013CN102276625B 噻二唑衍生物 Thiadiazole derivatives
07/17/2013CN101910182B Antitumor agent
07/16/2013US8487119 Organic sensitizers
07/16/2013US8487114 Fused thiophenes and methods for making and using same
07/16/2013US8487101 Thieno-pyridine derivatives as MEK inhibitors
07/16/2013US8486953 Thienopyrimidines for pharmaceutical compositions
07/16/2013US8486952 Compounds for the reduction of β-amyloid production
07/16/2013US8486948 Piperazinodihydrothienopyrimidine derivatives
07/11/2013US20130178475 sGC STIMULATORS
07/11/2013US20130178460 Thienopyrimidine compounds
07/11/2013US20130178459 Tricyclic compounds and pbk inhibitors containing the same
07/11/2013US20130178453 Cannabinoid Agonists
07/11/2013US20130175507 Novel Heterocyclic Host Materials
07/10/2013EP2611814A1 Method for producing dithiin-tetracarboximides
07/10/2013EP2611813A1 Dithiin-tetra(thio) carboximides for controlling phytopathogenic fungi
07/10/2013EP2611812A1 Thienopyridine and thienopyrimidine compounds and methods of use thereof
07/10/2013EP2611804A1 Novel compounds and compositions for the inhibition of nampt
07/10/2013EP2611801A1 Herbicidally active ketosultams and diketopyridines
07/10/2013EP2611798A1 Pyridazinones, method of making, and method of use thereof
07/10/2013CN103201277A Pyridazinones, method of making, and method of use thereof
07/10/2013CN103193962A Bithiophene benzobithiophene conjugated polymer material and preparation method and application thereof
07/10/2013CN103193793A Salicylic acid functionalized (3, 4-ethylenedioxythiophene) monomer, polymer and preparation methods thereof
07/10/2013CN103193792A New compound for treating ischemic cardiovascular and cerebrovascular diseases
07/10/2013CN101906093B Benzo five-membered unsaturated heterocycle compound and preparation method thereof
07/09/2013US8481584 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
07/09/2013CA2608726C Inhibitors of vegf receptor and hgf receptor signaling
07/09/2013CA2567268C Thienopyridinone compounds and methods of treatment
07/04/2013WO2013100632A1 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
07/04/2013WO2013099523A1 Novel organic compound
07/04/2013WO2013098746A1 Fullerenes functionalized with thienylene for photovoltaics
07/04/2013WO2013098726A1 Benzodithiophene derivatives and their use as photoluminescent compounds
07/04/2013WO2013097226A1 Fused tetra or penta-cyclic pyridophthalazinones as parp inhibitors
07/04/2013US20130174286 In Vivo Gene Silencing By Chemically Modified and Stable siRNA
07/04/2013US20130172553 Chiral synthesis of isoxazolines, isoxazoline compounds, and uses thereof
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 214